In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Clinical Genomics completes $26mm second round

Executive Summary

Liquid biopsy developer Clinical Genomics Pty. Ltd. raised $26mm through what is assumed to be its Series B round. New investors Moelis Australia Asset Management and Regal were joined by returning backers Quest Diagnostics and OneVentures. Proceeds will go towards commercialization of the Colvera blood test for early detection of colorectal cancer recurrence, and will also support development of the test as a colorectal cancer screening tool.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies